Lazcluze 240 mg, Filmtabletten

7680697510025 CH-69751 Filmtabletten
Lazcluze 240 mg, Filmtabletten
Lazcluze 240 mg, Filmtabletten
Lazcluze 240 mg, Filmtabletten
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/04/2025
Patient information leaflet
Français
02/04/2025
Patient information leaflet
Italien
02/04/2025
Summary of Product Characteristics
Allemand
02/04/2025
Summary of Product Characteristics
Français
02/04/2025
Summary of Product Characteristics
Italien
02/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
240.0 MG Substance Wirkstoff (Principe actif)
(N/A)
289.44 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 6763.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2025

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
69751
Drug name
Lazcluze, Filmtabletten
Galenic form
FILM
ATC Code
L01EB09
Authorization status
Z
Dispensing category
A
First authorization
07/02/2025
Authorization expiration date
06/02/2030
IT Number
07.16.1.
Domain
Human medicine
Field of application
nicht-kleinzelliges Lungenkarzinom (NSCLC)

Package details

Description (FR)
LAZCLUZE cpr pellic 240 mg 28 pce
Description (DE)
LAZCLUZE Filmtabl 240 mg 28 Stk
Market launch
27/06/2025
Narcotic (BTM)
No

Other package sizes (1)

LAZCLUZE cpr pellic 80 mg 56 pce
56 TABL
GTIN: 7680697510018
View